The combination of a balanced diet, exercise, and accountability will help you reach sustainable goals
Editorial Advisory Board Member, Harvard Health Publishing Popular GLP-1 medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) typically cause people to eat less
In clinical trials for Ozempic (subcutaneous semaglutide for diabetes), diarrhea occurred in approximately 8.5% of patients receiving 0.5 mg and 8.3% of patients receiving 1 mg doses, compared to 4.3% in placebo groups
blood sugar) into your bodys cells, where its used for energy
David LaMond, Medical Director, Blue Sky MD GLP-1 receptor agonistslike semaglutide and tirzepatidehave transformed how we treat obesity and metabolic disease